在优化的反应条件下，系统地验证了RECOGNIZER的检测性能。RECOGNIZER对核酸片段的最低检出限达5.42 ...

Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...

1月3日，白宫宣布授予23位世界级研究人员国家科学奖章和国家技术创新奖章，其中14人获国家科学奖章，9人及两家组织获国家技术创新奖章，张锋是国家技术和创新奖章获奖者之一。

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

虽然但是，还有整整75年，不知道还有多少新奇玩意会被突破。 但就这20几年，至少有几项我感觉是跑不掉"名留青史"的。 1.人类基因组（Human Genome Project，2000） ...

CRISPR Therapeutics AG (CRSP) closed at $43.42 in the latest trading session, marking a -1.83% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.29%. Meanwhile ...

If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...

As translational CRISPR-based research continues to make waves in laboratories and the clinic, scientists across life science disciplines pursue out-of-the-ordinary genome editing applications. From ...

Financial disclosures released ahead of confirmation hearings for Robert F. Kennedy Jr., President Trump’s nominee to lead the health ...